Portfolio company
ProVerum
Ireland · £63.2m raised
Raised
£63.2m
Latest stage
Series B
Rounds recorded
1
Backed by
2 investors
Sectors
About
This company develops minimally invasive nitinol stents to treat benign prostatic hyperplasia in male patients.
SourceFunding history · 1
Similar companies
ProVerum Medical
The company develops a minimally invasive urethral stent system to treat benign prostatic hyperplasia for urologists and patients.
ArgoMed
This company develops water-induced thermotherapy devices for the non-surgical treatment of benign prostatic hyperplasia in male patients.
Alpfa Medical
The company develops pulsed field ablation systems to treat benign prostatic hyperplasia in men.
NXThera
This company develops water vapour therapy systems to treat patients suffering from enlarged prostate and prostate cancer.
TRANSURETHRAL IMAGING & THERAPY
This company develops a transurethral ultrasound imaging and high-intensity focused ultrasound therapy system for urologists to treat prostate disease in outpatient procedures.
Vivifi Medical
Vivifi Medical develops a laparoscopic surgical device for clinicians to treat benign prostatic hyperplasia and male infertility by reconnecting blood vessels.
Trod Medical
The company develops radio frequency ablation devices for treating prostate cancer for use by urological surgeons and healthcare providers.
Promaxo, Inc
The company develops a point-of-care MRI platform for urologists to perform guided prostate biopsies and treatments in clinical settings.
